tirilazad mesylate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 1991 (NCT00004759)
Timeline
1990s
- Jan 1, 1991
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetOTHER
Lipid peroxidation inhibitor
Lipid peroxidation inhibitor (radical scavenging and membrane stabilizing).
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1- Mol. weight
- 624.87 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1630578 ↗
- ChEMBLCHEMBL1908849 ↗
- ChEMBLCHEMBL1908330 ↗
Also known as
- 21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methylpregna-1,4,9(11)-triene-3,20-dione monomethane sulfonate
- freedox
- freedox
- pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methyl-, (16alpha)-, monomethanesulfonate
- tirilazad
- tirilazad
- tirilazad
- tirilazad
- tirilazad
- tirilazad
- tirilazad
- tirilazad mesilate
- tirilazad mesylate
- tirilazad mesylate
- tirilazad mesylate
- tirilazad mesylate
- tirilazad mesylate
- tirilazad mesylate hydrate
- u-74006
- u74006f
- u 74006f
- u-74006f
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004759 | Phase 3 | Dec 1, 1991 | National Institute of Neurological Disorders and Stroke (NINDS), Yale University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Government | 1 | 1 | 1 | 1991 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 1991 |
2 organizations
Page 1 / 1